Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgia Santilli

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Molecular Diagnosis & Therapy|October 14, 2022
Gene Editing in Human Haematopoietic Stem Cells for the Treatment of Primary ImmunodeficienciesSameer Bahal, Klesti Karaxhuku, Giorgia Santilli
The Journal of Biological Chemistry|July 29, 2003
Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activityGiorgia Santilli, Bruce J Aronow, Arturo Sala
Scientific Reports|September 2, 2017
Characterization of a core region in the A2UCOE that confers effective anti-silencing activityFang Zhang, Giorgia Santilli, Adrian J Thrasher
Oncoimmunology|July 30, 2013
Catechins and antitumor immunity: Not MDSC's cup of teaGiorgia Santilli, John Anderson, Adrian J Thrasher, et al.
Expert Opinion on Biological Therapy|March 21, 2008
Gene therapy of inherited immunodeficienciesGiorgia Santilli, Susannah I Thornhill, Christine Kinnon, et al.
Human Gene Therapy|June 14, 2012
Gene therapy for primary immunodeficienciesChristine Rivat, Giorgia Santilli, H Bobby Gaspar, et al.
Blood|April 19, 2003
Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiationKaren Keeshan, Giorgia Santilli, Francesca Corradini, et al.
The Journal of Biological Chemistry|December 25, 2004
Temperature-dependent modification and activation of B-MYB: implications for cell survivalGiorgia Santilli, Rebekka Schwab, Roger Watson, et al.
Human Gene Therapy|November 28, 2019
Differential Transgene Silencing of Myeloid-Specific Promoters in the <i>AAVS1</i> Safe Harbor Locus of Induced Pluripotent Stem Cell-Derived Myeloid CellsDenise Klatt, Erica Cheng, Dirk Hoffmann, et al.
Molecular Therapy. Methods & Clinical Development|March 23, 2023
An improved medium formulation for efficient <i>ex vivo</i> gene editing, expansion and engraftment of hematopoietic stem and progenitor cellsRajeev Rai, Asma Naseem, Winston Vetharoy, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Molecular Diagnosis & Therapy|October 14, 2022
Gene Editing in Human Haematopoietic Stem Cells for the Treatment of Primary ImmunodeficienciesSameer Bahal, Klesti Karaxhuku, Giorgia Santilli
The Journal of Biological Chemistry|July 29, 2003
Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activityGiorgia Santilli, Bruce J Aronow, Arturo Sala
Scientific Reports|September 2, 2017
Characterization of a core region in the A2UCOE that confers effective anti-silencing activityFang Zhang, Giorgia Santilli, Adrian J Thrasher
Oncoimmunology|July 30, 2013
Catechins and antitumor immunity: Not MDSC's cup of teaGiorgia Santilli, John Anderson, Adrian J Thrasher, et al.
Expert Opinion on Biological Therapy|March 21, 2008
Gene therapy of inherited immunodeficienciesGiorgia Santilli, Susannah I Thornhill, Christine Kinnon, et al.
Human Gene Therapy|June 14, 2012
Gene therapy for primary immunodeficienciesChristine Rivat, Giorgia Santilli, H Bobby Gaspar, et al.
Blood|April 19, 2003
Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiationKaren Keeshan, Giorgia Santilli, Francesca Corradini, et al.
The Journal of Biological Chemistry|December 25, 2004
Temperature-dependent modification and activation of B-MYB: implications for cell survivalGiorgia Santilli, Rebekka Schwab, Roger Watson, et al.
Human Gene Therapy|November 28, 2019
Differential Transgene Silencing of Myeloid-Specific Promoters in the <i>AAVS1</i> Safe Harbor Locus of Induced Pluripotent Stem Cell-Derived Myeloid CellsDenise Klatt, Erica Cheng, Dirk Hoffmann, et al.
Molecular Therapy. Methods & Clinical Development|March 23, 2023
An improved medium formulation for efficient <i>ex vivo</i> gene editing, expansion and engraftment of hematopoietic stem and progenitor cellsRajeev Rai, Asma Naseem, Winston Vetharoy, et al.
Pageof 5